Clinical and Laboratory Factors Associated With the Severity of Proliferative Sickle Cell Retinopathy in Patients With Sickle Cell Hemoglobin C (SC) and Homozygous Sickle Cell (SS) Disease
Authors:
- Nicolas MD LevezielNLNicolas MD Leveziel
- Sylvie Bastuji-GarinSBSylvie Bastuji-Garin
- Franck LalloumFLFranck Lalloum
- Giuseppe QuerquesGQGiuseppe Querques
- Pascale BenlianPBPascale Benlian
- Michel BinaghiMBMichel Binaghi
- Gabriel CoscasGCGabriel Coscas
- Gisèle SoubraneGSGisèle Soubrane
- Dora BachirDBDora Bachir
- Frédéric GalactérosFGFrédéric Galactéros
- Eric H. SouiedESEric H. Souied
- 1 November 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 90 (6) , 372-378
Abstract
Proliferative sickle cell retinopathy (PSCR) is the most frequent vision-threatening complication of sickle cell disease (SCD). We investigated the relationship between the severity of sickle cell retinopathy in heterozygous (SC) or homozygous (SS) adult SCD patients and the clinical and laboratory data obtained during visits to a national SCD referral center. This retrospective longitudinal analysis included 942 SCD patients (313 patients with SC and 629 with SS disease) with ophthalmologic evaluations who were followed over a 19-year period by a multidisciplinary team in a referral center. PSCR was graded using the Goldberg classification. We identified patient and SCD characteristics associated with sickle cell retinopathy severity using multinomial logistic-regression models. Multivariate analysis associated severe PSCR forms (stages III-V) with older age (p = 0.032), pulmonary involvement (documented pulmonary hypertension with pulmonary arterial pressure ≥40 mm Hg, restrictive syndrome >20%, or previous history of pulmonary embolism diagnosed by vascular imaging) (p = 0.029), deafness or tinnitus (p = 0.026), and no history of osteomyelitis (p = 0.013) for SC patients; and with older age (p < 0.001), male sex (p = 0.003), and acute pyelonephritis (p = 0.04) for SS patients. The model of severe PSCR versus no PSCR showed good calibration and discrimination for SC and SS patients. Awareness of the clinical and laboratory factors significantly associated with severe PSCR in patients with SC or SS SCD may contribute to improved preventive strategies. Abbreviations: CI = confidence interval, HbF = fetal hemoglobin, OR = odds ratio, PSCR = proliferative sickle cell retinopathy, SC = sickle cell hemoglobin C disease, SCD = sickle cell disease, SS = homozygous sickle cell disease.Keywords
This publication has 22 references indexed in Scilit:
- Association of the +874 T/A interferon gamma polymorphism with infections in sickle cell diseaseInternational Journal of Immunogenetics, 2010
- Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouseAmerican Journal of Hematology, 2009
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2007
- Incidence and Natural History of Proliferative Sickle Cell RetinopathyOphthalmology, 2005
- Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell DiseaseNew England Journal of Medicine, 2004
- Gender and haplotype effects upon hematological manifestations of adult sickle cell anemiaAmerican Journal of Hematology, 1995
- Risk factors for proliferative sickle retinopathy.British Journal of Ophthalmology, 1990
- Sickle cell retinopathy in Jamaican children: further observations from a cohort study.British Journal of Ophthalmology, 1988
- Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.Journal of Clinical Investigation, 1984
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984